𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interferon alfa for chronic hepatitis B infection: Increased efficacy of prolonged treatment

✍ Scribed by Harry L. Janssen; Guido Gerken; Vicente Carreño; Patrick Marcellin; Nikolai V. Naoumov; Antonio Craxi; Helmer Ring-Larsen; George Kitis; Jan van Hattum; Richard A. de Vries; Peter P. Michielsen; Fiebo J. ten Kate; Wim C. Hop; Rudolf A. Heijtink; Pieter Honkoop; Solko W. Schalm

Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
104 KB
Volume
30
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon alfa-2b in combination with r
Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: Efficacy, safety, and pharmacokinetics
✍ Regino P. González-Peralta; Deirdre A. Kelly; Barbara Haber; Jean Molleston; Kar 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 3 views

Chronic hepatitis C virus (HCV) infection is usually asymptomatic in children, but significant liver disease may occur. We evaluated the efficacy, safety, and pharmacokinetics of interferon alfa-2b and ribavirin in children with chronic HCV. We determined the optimal ribavirin dose in an initial coh

Cost-effectiveness of interferon alfa 2b
Cost-effectiveness of interferon alfa 2b and ribavirin in the treatment of chronic hepatitis C
✍ W. Ray Kim; John J. Poterucha 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB 👁 2 views

In their paper in the November issue of HEPATOLOGY, Younossi et al. 1 may have overestimated the cost effectiveness of interferon-ribavirin treatment. This mainly stems from their failure to take into account the fact that patients who achieve sustained response are not homogenous with respect to th

Treatment of chronic type B hepatitis wi
Treatment of chronic type B hepatitis with recombinant α-interferon induces autoantibodies not specific for autoimmune chronic hepatitis
✍ Werner-J. Mayet; Georg Hess; Guido Gerken; Siegbert Rossol; Rita Voth; Michael M 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB 👁 1 views

Recombinant human a-interferon is now under intensive investigation as therapy for chronic Type B hepatitis. Recent reports have suggested that prolonged a- interferon therapy may induce autoimmune reactions. We have evaluated the problem of autoimmunity related to a-interferon therapy by testing fo